Hosted on MSN3mon
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?The top 10 holdings account for about 45.06% of total assets under management. So far this year, PBE has gained about 1.19%, and is up about 18.40% in the last one year (as of 11/20/2024).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results